Bluebird Bio - 1 Year Dividend History | BLUE
Historical dividend payout and yield for Bluebird Bio (BLUE) since 2023. The current TTM dividend payout for Bluebird Bio (BLUE) as of November 29, 2024 is $0.00. The current dividend yield for Bluebird Bio as of November 29, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.079B |
$0.030B |
|
bluebird bio, Inc. is a clinical-stage biotechnology that is focused on developing gene therapies for severe genetic diseases and cancer. The company has developed a deep pipeline using lentiviral-based gene therapies, T-cell immunotherapy expertise, and gene editing capabilities to treat severe genetic diseases as well as cancer.?The pipeline for severe genetic diseases includes betibeglogene autotemcel (beti-cel) for the treatment of transfusion-dependent ?-thalassemia (TDT).
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
